文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

COVID-19 与甲型流感病毒在血液透析患者中的合并感染:一例报告。

Co-infection of COVID-19 and influenza A in a hemodialysis patient: a case report.

机构信息

Department of Internal Medicine, University of Nebraska College of Medicine, 985520 Nebraska Medical Center, Omaha, NE, 68198, USA.

Penn State College of Medicine, 700 HMC Crescent Road, Hershey, PA, 17033, USA.

出版信息

BMC Infect Dis. 2021 Jan 13;21(1):68. doi: 10.1186/s12879-020-05723-y.


DOI:10.1186/s12879-020-05723-y
PMID:33441085
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7804903/
Abstract

BACKGROUND: Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus that was first discovered in December 2019 in Wuhan, China. With the growing numbers of community spread cases worldwide, the World Health Organization (WHO) declared the COVID-19 outbreak as a pandemic on March 11, 2020. Like influenza viruses, SARS-CoV-2 is thought to be mainly transmitted by droplets and direct contact, and COVID-19 has a similar disease presentation to influenza. Here we present a case of influenza A and COVID-19 co-infection in a 60-year-old man with end-stage renal disease (ESRD) on hemodialysis. CASE PRESENTATION: A 60-year-old man with ESRD on hemodialysis presented for worsening cough, shortness of breath, and diarrhea. The patient first developed a mild fever (37.8 °C) during hemodialysis 3 days prior to presentation and has been experiencing worsening flu-like symptoms, including fever of up to 38.6 °C, non-productive cough, generalized abdominal pain, nausea, vomiting, and liquid green diarrhea. He lives alone at home with no known sick contacts and denies any recent travel or visits to healthcare facilities other than the local dialysis center. Rapid flu test was positive for influenza A. Procalcitonin was elevated at 5.21 ng/mL with a normal white blood cell (WBC) count. Computed tomography (CT) chest demonstrated multifocal areas of consolidation and extensive mediastinal and hilar adenopathy concerning for pneumonia. He was admitted to the biocontainment unit of Nebraska Medicine for concerns of possible COVID-19 and was started on oseltamivir for influenza and vancomycin/cefepime for the probable bacterial cause of his pneumonia and diarrhea. Gastrointestinal (GI) pathogen panel and Clostridioides difficile toxin assay were negative. On the second day of admission, initial nasopharyngeal swab came back positive for SARS-CoV-2 by real-time reverse-transcriptase polymerase chain reaction (RT-PCR). The patient received supportive care and resumed bedside hemodialysis in strict isolation, and eventually fully recovered from COVID-19. CONCLUSIONS: We presented a case of co-infection of influenza and SARS-CoV-2 in a hemodialysis patient. The possibility of SARS-CoV-2 co-infection should not be overlooked even when other viruses including influenza can explain the clinical symptoms, especially in high-risk patients.

摘要

背景:2019 年冠状病毒病(COVID-19)是由严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)引起的,这是一种新型冠状病毒,于 2019 年 12 月在中国武汉首次发现。随着全球社区传播病例数量的增加,世界卫生组织(WHO)于 2020 年 3 月 11 日宣布 COVID-19 疫情为大流行。像流感病毒一样,SARS-CoV-2 被认为主要通过飞沫和直接接触传播,COVID-19 的疾病表现与流感相似。在这里,我们报告了一例 60 岁男性透析患者同时感染甲型流感和 COVID-19。

病例介绍:一名 60 岁男性,患有终末期肾病(ESRD),正在接受血液透析,因咳嗽加重、呼吸急促和腹泻就诊。该患者在就诊前 3 天在血液透析过程中首次出现轻度发热(37.8°C),并一直出现类似流感的症状加重,包括高达 38.6°C 的发热、干咳、全身腹痛、恶心、呕吐和绿色稀便。他独自在家居住,没有已知的患病接触者,也否认最近有旅行或除当地透析中心以外的任何医疗机构就诊史。快速流感检测呈甲型流感阳性。降钙素原升高至 5.21ng/mL,白细胞(WBC)计数正常。胸部计算机断层扫描(CT)显示多灶性实变和广泛的纵隔和肺门淋巴结肿大,考虑肺炎。由于可能感染 COVID-19,他被收入内布拉斯加州医学的生物隔离病房,并开始接受奥司他韦治疗流感,万古霉素/头孢吡肟治疗可能导致他肺炎和腹泻的细菌感染。胃肠道(GI)病原体检测和艰难梭菌毒素检测均为阴性。入院第二天,初始鼻咽拭子通过实时逆转录-聚合酶链反应(RT-PCR)检测出 SARS-CoV-2 呈阳性。患者接受了支持性治疗,并在严格隔离下恢复床边血液透析,最终完全从 COVID-19 中康复。

结论:我们报告了一例血液透析患者同时感染流感和 SARS-CoV-2 的病例。即使其他病毒(包括流感)可以解释临床症状,特别是在高危患者中,也不应忽视 SARS-CoV-2 合并感染的可能性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7830/7807900/37f67b8f5af9/12879_2020_5723_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7830/7807900/bf560e39d716/12879_2020_5723_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7830/7807900/37f67b8f5af9/12879_2020_5723_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7830/7807900/bf560e39d716/12879_2020_5723_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7830/7807900/37f67b8f5af9/12879_2020_5723_Fig2_HTML.jpg

相似文献

[1]
Co-infection of COVID-19 and influenza A in a hemodialysis patient: a case report.

BMC Infect Dis. 2021-1-13

[2]
Late diagnosis of respiratory syncytial virus and influenza co-infection during coronavirus disease 2019 pandemic: a case report.

J Med Case Rep. 2023-10-21

[3]
Coronavirus disease 2019 (COVID-19) pneumonia in a hemodialysis patient: A case report.

Medicine (Baltimore). 2020-7-2

[4]
Evaluation of Three Multiplex Real-time Reverse Transcription PCR Assays for Simultaneous Detection of SARS-CoV-2, Influenza A/B, and Respiratory Syncytial Virus in Nasopharyngeal Swabs.

J Korean Med Sci. 2021-12-13

[5]
Co-infection of Coronavirus Disease 2019 and Influenza A: A Report from Iran.

Arch Iran Med. 2020-4-1

[6]
Multicenter study evaluating one multiplex RT-PCR assay to detect SARS-CoV-2, influenza A/B, and respiratory syncytia virus using the LabTurbo AIO open platform: epidemiological features, automated sample-to-result, and high-throughput testing.

Aging (Albany NY). 2021-12-12

[7]
Co-infection with SARS-CoV-2 and parainfluenza virus in a hemodialysis patient: A case report.

Clin Nephrol. 2020-10

[8]
Co-infection of influenza A virus and SARS-CoV-2: A retrospective cohort study.

J Med Virol. 2021-5

[9]
Coinfection With SARS-CoV-2 and Influenza A(H1N1) in a Patient Seen at an Influenza-like Illness Surveillance Site in Egypt: Case Report.

JMIR Public Health Surveill. 2021-4-28

[10]
Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.

Trials. 2021-4-2

引用本文的文献

[1]
Altered microbiota of the lower respiratory tract and its association with COVID-19 severity analysed by metagenomics and metatranscriptomics.

Commun Biol. 2025-5-26

[2]
Serum metabolomic characteristics of COVID-19 patients co-infection with echovirus.

Virulence. 2025-12

[3]
A systematic review of the clinical characteristics of influenza-COVID-19 co-infection.

Clin Exp Med. 2023-11

[4]
COVID-19 and Respiratory Virus Co-Infections: A Systematic Review of the Literature.

Viruses. 2023-3-28

[5]
A case of Co-infection COVID-19 and influenza with psychotic symptoms.

Heliyon. 2023-4

[6]
Do COVID-19 CT features vary between patients from within and outside mainland China? Findings from a meta-analysis.

Front Public Health. 2022

[7]
The microbiota-related coinfections in COVID-19 patients: a real challenge.

Beni Suef Univ J Basic Appl Sci. 2021

[8]
Immunopathological similarities between COVID-19 and influenza: Investigating the consequences of Co-infection.

Microb Pathog. 2021-3

本文引用的文献

[1]
Prevalence of Asymptomatic SARS-CoV-2 Infection : A Narrative Review.

Ann Intern Med. 2020-6-3

[2]
Co-infections in people with COVID-19: a systematic review and meta-analysis.

J Infect. 2020-5-27

[3]
Remdesivir for the Treatment of Covid-19 - Final Report.

N Engl J Med. 2020-10-8

[4]
Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry.

Gastroenterology. 2020-5-18

[5]
Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens.

JAMA. 2020-5-26

[6]
Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) - United States, February 12-March 16, 2020.

MMWR Morb Mortal Wkly Rep. 2020-3-27

[7]
Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis.

Clin Chim Acta. 2020-6

[8]
Clinical Characteristics of Coronavirus Disease 2019 in China.

N Engl J Med. 2020-2-28

[9]
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.

JAMA. 2020-4-7

[10]
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.

Allergy. 2020-2-27

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索